P. D. Lucas

发表

Reversible reduction in bone blood flow in streptozotocin-diabetic rats

P. D. Lucas, 1987, Experientia.

Novel fluorinated benzimidazole-based scaffolds and their anticancer activity in vitro

V. Kryštof, S. Teat, F. Zeinali, 2016 .

Mono-, di- and tri-nuclear manganese(II) complexes derived from a quinquedentate ligand: Superoxide dismutase and catalase mimetic studies

V. McKee, M. Kose, P. D. Lucas, 2015 .

Synthesis and antibacterial activity of bis[2-amino-4-phenyl-5-thiazolyl] disulfides.

G. Weaver, M. Zia-ur-Rehman, H. Siddiqui, 2007, Chemical & pharmaceutical bulletin.

Tissue noradrenaline and the polyol pathway in experimentally diabetic rats

A. Qirbi, P. D. Lucas, 1989, British journal of pharmacology.

Muscarinic receptor density is reduced in diabetic rat atria, an effect prevented by the aldose reductase inhibitor, Statil

P. D. Lucas, A. Kofo-Abayomi, 1987, The Journal of pharmacy and pharmacology.

Effects of Diabetes on Transmission in Two Preparations Cholinergic Rat Gut

A. M. Sardar, P. D. Lucas, 1991 .

Effects of streptozotocin-induced diabetes and noradrenaline infusion on cardiac output and its regional distribution in pithed rats

P. D. Lucas, 1985, Diabetologia.

A comparison between atria from control and streptozotocin‐diabetic rats: The effects of dietary myoinositol

P. D. Lucas, A. Kofo-Abayomi, 1988, British journal of pharmacology.